175 related articles for article (PubMed ID: 36550153)
1. MicroRNAs within the Basal-like signature of Quadruple Negative Breast Cancer impact overall survival in African Americans.
Angajala A; Raymond H; Muhammad A; Uddin Ahmed MS; Haleema S; Haque M; Wang H; Campbell M; Martini R; Karanam B; Kahn AG; Bedi D; Davis M; Tan M; Dean-Colomb W; Yates C
Sci Rep; 2022 Dec; 12(1):22178. PubMed ID: 36550153
[TBL] [Abstract][Full Text] [Related]
2. AR negative triple negative or "quadruple negative" breast cancers in African American women have an enriched basal and immune signature.
Davis M; Tripathi S; Hughley R; He Q; Bae S; Karanam B; Martini R; Newman L; Colomb W; Grizzle W; Yates C
PLoS One; 2018; 13(6):e0196909. PubMed ID: 29912871
[TBL] [Abstract][Full Text] [Related]
3. miRNA-135b Contributes to
Uva P; Cossu-Rocca P; Loi F; Pira G; Murgia L; OrrĂ¹ S; Floris M; Muroni MR; Sanges F; Carru C; Angius A; De Miglio MR
Int J Med Sci; 2018; 15(6):536-548. PubMed ID: 29725243
[TBL] [Abstract][Full Text] [Related]
4. A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer.
Turkistani S; Sugita BM; Fadda P; Marchi R; Afsari A; Naab T; Apprey V; Copeland RL; Campbell MC; Cavalli LR; Kanaan Y
BMC Cancer; 2021 Jul; 21(1):861. PubMed ID: 34315420
[TBL] [Abstract][Full Text] [Related]
5. Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer.
Kim YJ; Sung M; Oh E; Vrancken MV; Song JY; Jung K; Choi YL
Cancer Biol Ther; 2018 Apr; 19(4):335-345. PubMed ID: 29333926
[TBL] [Abstract][Full Text] [Related]
6. Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
Ademuyiwa FO; Tao Y; Luo J; Weilbaecher K; Ma CX
Breast Cancer Res Treat; 2017 Feb; 161(3):491-499. PubMed ID: 27915434
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
Keenan T; Moy B; Mroz EA; Ross K; Niemierko A; Rocco JW; Isakoff S; Ellisen LW; Bardia A
J Clin Oncol; 2015 Nov; 33(31):3621-7. PubMed ID: 26371147
[TBL] [Abstract][Full Text] [Related]
8. Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients.
Andey T; Attah MM; Akwaaba-Reynolds NA; Cheema S; Parvin-Nejad S; Acquaah-Mensah GK
Gene; 2020 Dec; 763S():100030. PubMed ID: 34493366
[TBL] [Abstract][Full Text] [Related]
9. QNBC Is Associated with High Genomic Instability Characterized by Copy Number Alterations and miRNA Deregulation.
Bhattarai S; Sugita BM; Bortoletto SM; Fonseca AS; Cavalli LR; Aneja R
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768979
[TBL] [Abstract][Full Text] [Related]
10. Differential methylation and expression patterns of microRNAs in relation to breast cancer subtypes among American women of African and European ancestry.
Gong Z; Chen J; Wang J; Liu S; Ambrosone CB; Higgins MJ
PLoS One; 2021; 16(3):e0249229. PubMed ID: 33784351
[TBL] [Abstract][Full Text] [Related]
11. Potential epigenetic modifications implicated in triple- to quadruple-negative breast cancer transition: a review.
Muhammad A; Forcados GE; Katsayal BS; Bako RS; Aminu S; Sadiq IZ; Abubakar MB; Yusuf AP; Malami I; Faruk M; Ibrahim S; Pase PA; Ahmed S; Abubakar IB; Abubakar M; Yates C
Epigenomics; 2022 Jun; 14(11):711-726. PubMed ID: 35473304
[TBL] [Abstract][Full Text] [Related]
12. Integrative analysis of breast cancer profiles in TCGA by TNBC subgrouping reveals novel microRNA-specific clusters, including miR-17-92a, distinguishing basal-like 1 and basal-like 2 TNBC subtypes.
Kalecky K; Modisette R; Pena S; Cho YR; Taube J
BMC Cancer; 2020 Feb; 20(1):141. PubMed ID: 32085745
[TBL] [Abstract][Full Text] [Related]
13. MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3.
Bai X; Han G; Liu Y; Jiang H; He Q
Biomed Pharmacother; 2018 Jul; 103():1482-1489. PubMed ID: 29864933
[TBL] [Abstract][Full Text] [Related]
14. High expression of MKK3 is associated with worse clinical outcomes in African American breast cancer patients.
Yang X; Amgad M; Cooper LAD; Du Y; Fu H; Ivanov AA
J Transl Med; 2020 Sep; 18(1):334. PubMed ID: 32873298
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
16. A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.
Wang DY; Gendoo DMA; Ben-David Y; Woodgett JR; Zacksenhaus E
Breast Cancer Res; 2019 Jan; 21(1):18. PubMed ID: 30704524
[TBL] [Abstract][Full Text] [Related]
17. Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets.
Farazi TA; Ten Hoeve JJ; Brown M; Mihailovic A; Horlings HM; van de Vijver MJ; Tuschl T; Wessels LF
Genome Biol; 2014 Jan; 15(1):R9. PubMed ID: 24398324
[TBL] [Abstract][Full Text] [Related]
18. In Silico Identification of a BRCA1:miR-29:DNMT3 Axis Involved in the Control of Hormone Receptors in BRCA1-Associated Breast Cancers.
Santarosa M; Baldazzi D; Armellin M; Maestro R
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373065
[TBL] [Abstract][Full Text] [Related]
19. Race Disparities in the Contribution of miRNA Isoforms and tRNA-Derived Fragments to Triple-Negative Breast Cancer.
Telonis AG; Rigoutsos I
Cancer Res; 2018 Mar; 78(5):1140-1154. PubMed ID: 29229607
[TBL] [Abstract][Full Text] [Related]
20. The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer.
Paul U; Banerjee S
Mol Biol Rep; 2022 Jul; 49(7):6899-6918. PubMed ID: 35235157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]